To extend the application of human skin explants to in vivo gene therapy, Lippin et al. obtained skin explants from patients with chronic renal failure and anemia, injected them with an adenovirus expressing human erythropoietin, and reimplanted them into the patients [18]. Here, EPO is linked to chronic kidney disease.